Jerusalem Pharmaceuticals Market Cap

Jerusalem Pharmaceuticals has a market cap or net worth of 60.58 million as of December 5, 2025. Its market cap has increased by 46.05% in one year.

Market Cap

60.58M

Enterprise Value

54.80M

Revenue

33.42M

Ranking

n/a

PE Ratio

8.69

Stock Price

4.75

Market Cap Chart

Since December 15, 2008, Jerusalem Pharmaceuticals's market cap has increased from 14.89M to 60.58M, an increase of 306.86%. That is a compound annual growth rate of 8.62%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	60.58M	23.76%
Dec 24, 2024	48.95M	0.78%
Dec 31, 2023	48.57M	15.89%
Dec 29, 2022	41.91M	16.10%
Dec 23, 2021	36.10M	2.12%
Dec 31, 2020	35.35M	-1.04%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Palestine Telecommunications Company P.L.C	671.29M
Palestine Development & Investment Co.	345.12M
Bank of Palestine	304.70M
Arab Palestinian Investment Company	223.32M
Arkaan Real Estate P.L.C	193.97M
Wataniya Palestine Mobile Telecommunication - Public Shareholding Company	184.76M
The National Bank	120.26M
Birzeit Pharmaceuticals Company	109.92M

Market Cap Rankings